Subgroup analysis found significant benefits for patients with cancer, cardiovascular disease, or both.
Paxlovid tied to 30% lower risk of severe COVID in patients with chronic conditions
More from COVID-19More posts in COVID-19 »
.
Subgroup analysis found significant benefits for patients with cancer, cardiovascular disease, or both.